Kapoor Poonam Malhotra, Dhawan Ira, Jain Pawan, Chowdhury Ujjwal
Department of Cardiac Anaesthesia, Cardio Thoracic Centre, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Ann Card Anaesth. 2016 Apr-Jun;19(2):269-76. doi: 10.4103/0971-9784.179619.
Lactate and central venous oxygen saturation (ScVO2) are well known biomarkers for adequacy of tissue oxygenation. Endothelin, an inflammatory marker has been associated with patient's nutritional status and degree of cyanosis. The aim of this study was to explore the hypothesis that lactate, ScVO2 and endothelin before induction may be predictive of mortality in pediatric cardiac surgery.
We conducted a prospective observational study of 150 pediatric (6 months to 12 years) patients who were posted for intracardiac repair for Tetralogy of Fallot and measured lactate, ScVO2 and endothelin before induction (T1), 20 minutes after protamine administration (T2) and 24 hours after admission to ICU (T3).
Preinduction lactate and endothelin levels were found to predict mortality in patients of Tetralogy of Fallot with an odds ratio of 6.020 (95% CI 2.111-17.168) and 1.292(95% CI 1.091-1.531) respectively. In the ROC curve analysis for lactate at T1, the AUC was 0.713 (95% CI 0.526-0.899 P = 0.019). At the cutoff value of 1.750 mmol/lt, the sensitivity and specificity for the prediction of mortality was 63.6% and 65.5%, respectively. For endothelin at T1, the AUC was 0.699 (95% CI 0.516-0.883, P = 0.028) and the cutoff value was ≤2.50 (sensitivity, 63.6%; specificity, 58.3 %). ScVO2 (odds ratio 0.85) at all three time intervals, suggested that improving ScVO2 can lead to 15% reduction in mortality.
Lactate, ScVO2 and endothelin all showed association with mortality with lactate having the maximum prediction. Lactate was found to be an independent, reliable and cost-effective measure of prediction of mortality in patients with Tetralogy of Fallot.
乳酸和中心静脉血氧饱和度(ScVO2)是组织氧合充足程度的著名生物标志物。内皮素作为一种炎症标志物,与患者的营养状况和发绀程度有关。本研究的目的是探讨诱导前乳酸、ScVO2和内皮素可能预测小儿心脏手术死亡率的假设。
我们对150例接受法洛四联症心内修复手术的小儿患者(6个月至12岁)进行了一项前瞻性观察研究,在诱导前(T1)、鱼精蛋白给药后20分钟(T2)和入住重症监护病房24小时后(T3)测量乳酸、ScVO2和内皮素。
发现诱导前乳酸和内皮素水平可预测法洛四联症患者的死亡率,优势比分别为6.020(95%可信区间2.111-17.168)和1.292(95%可信区间1.091-1.531)。在T1时乳酸的ROC曲线分析中,曲线下面积(AUC)为0.713(95%可信区间0.526-0.899,P=0.019)。在临界值1.750 mmol/lt时,预测死亡率的敏感性和特异性分别为63.6%和65.5%。对于T1时的内皮素,AUC为0.699(95%可信区间0.516-0.883,P=0.028),临界值为≤2.50(敏感性,63.6%;特异性,58.3%)。在所有三个时间间隔的ScVO2(优势比0.85)表明,ScVO2的改善可导致死亡率降低15%。
乳酸、ScVO2和内皮素均与死亡率相关,其中乳酸的预测能力最强。乳酸被发现是预测法洛四联症患者死亡率的一种独立、可靠且具有成本效益的指标。